🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and efficacy of the combi...
Status
Completed
Location
St George's University Hospitals NHS Foundation Trust
Start Date
2018-10-04
Trial ID
NCT03711188
Treatments Being Tested
The purpose of this study is to investigate the safety and effects of IMM 1...
Status
Completed
Location
HCA International, The Sarah Cannon Research Institute
Start Date
2012-05-30
Trial ID
NCT01539824
Treatments Being Tested
To evaluate the safety and tolerability of intradermal injections of IMM-10...
Status
Completed
Location
HCA Clinical Trials Unit, 79 Harley Street,
Start Date
2010-03
Trial ID
NCT01308762
Trial to investigate if the addition of two novel immunotherapy agents in c...
Status
Withdrawn
Location
University Hospitals Bristol NHS Foundation Trust
Start Date
2024-06-17
Trial ID
NCT06498518
Treatments Being Tested
An Expanded Access Program for IMM-101 for patients with advanced pancreati...
Status
No Longer Available
Location
France
Start Date
TBD
Trial ID
NCT04137822
Treatments Being Tested
Patients who were previously enrolled in Study IMM-101-001 and who provided...
Status
Terminated
Location
St Georges University of London
Start Date
2012-02
Trial ID
NCT01559818
Treatments Being Tested
The purpose of this study is to find out if immunization with IMM-101 will ...
Status
Completed
Location
Juravinski Cancer Centre at Hamilton Health Sciences
Start Date
2020-10-01
Trial ID
NCT04442048
Treatments Being Tested
During this open label study patients will receive IMM-101 in conjunction w...
Status
Terminated
Location
Centre Léon Bérard, Dpt Medecine & INSERM
Start Date
2017-05-31
Trial ID
NCT03009058
To compare, in patients with advanced pancreatic cancer, the effects of IMM...
Status
Completed
Location
Cyprus Oncology Centre
Start Date
2011-06
Trial ID
NCT01303172
Treatments Being Tested
The investigators hypothesize that atezolizumab will improve the prognosis ...
Status
Active Not Recruiting
Location
Westdeutsches Tumorzentrum
Start Date
2021-12-10
Trial ID
NCT05118724
Treatments Being Tested